Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world study

Published:2018-02-15 Issue:5 Volume:90 Page:951-958
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Marciano Sebastián¹^ORCID,Haddad Leila¹,Reggiardo María V.²,Peralta Mirta³,Vistarini Cecilia⁴,Marino Mónica⁵,Descalzi Valeria I.⁶,D'Amico Claudia⁷,Figueroa Escuti Sebastián⁸,Gaite Luis A.⁹,Perez Ravier Roberto¹⁰,Longo Cristina¹¹,Borzi Silvia M.¹²,Galdame Omar A.¹,Bessone Fernando²,Fainboim Hugo A.³,Frías Silvia⁴,Cartier Mariano⁵,Gadano Adrián C.¹

Affiliation:

1. Hospital Italiano de Buenos AiresBuenos AiresArgentina

2. Hospital Provincial del CentenarioRosarioArgentina

3. Hospital F.J Muñiz,Buenos AiresArgentina

4. Hospital Ramos MejíaBuenos AiresArgentina

5. Hospital de Gastroenterología Carlos B. UdaondoBuenos AiresArgentina

6. Hospital Universitario Fundación FavaloroBuenos AiresArgentina

7. Centro de Especialidades Médicas Ambulatoria Mar del PlataBuenos AiresArgentina

8. Hospital Dr. OñativiaSaltaArgentina

9. Clínica de NefrologíaSanta FeArgentina

10. Hospital Central de MendozaMendozaArgentina

11. Hospital Nacional Prof. Alejandro PosadasBuenos AiresArgentina

12. Hospital R. RossiLa PlataBuenos AiresArgentina

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25033

Reference24 articles.

1. What is the impact of treatment for hepatitis C virus infection?

2. Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence

3. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

4. Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

5. Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Direct-Acting Antiviral Therapy Efficacy and Post-Treatment Fibrosis with Noninvasive Markers in Patients with Chronic Hepatitis C;Flora the Journal of Infectious Diseases and Clinical Microbiology;2023-12-22

2. Genotypes of Hepatitis C Virus and Efficacy of Direct-Acting Antiviral Drugs among Chronic Hepatitis C Patients in a Tertiary Care Hospital;Tropical Medicine and Infectious Disease;2023-01-30

3. Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C;World Journal of Clinical Cases;2022-12-06

4. Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis;ANN HEPATOL;2021

5. Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis;Annals of Hepatology;2021-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3